“Bone Marrow-on-a-Chip”: Replicating Hematopoiesis and Investigating the Impact of Ionizing Radiation
Steven C. George, Professor, University of California, Davis
Tissue engineering holds enormous potential to not only replace or
restore function to a wide range of tissues, but also to capture and
control 3D physiology in vitro (e.g., microphysiological systems or
“organ-on-a-chip” technology). The latter has important applications in
the fields of drug development, toxicity screening, modeling tumor
metastasis, and repairing damaged cardiac (heart) muscle. In order to
replicate the complex 3D arrangement of cells and extracellular matrix
(ECM), new human microphysiological systems must be developed. The past
decade has brought tremendous advances in our understanding of stem
cell technology and microfabrication producing a rich environment to
create an array of “organ-on-a-chip” designs. Over the past six years
we have developed novel microfluidic-based systems of 3D human
microtissues (~ 1 mm3) that contain features such as perfused
human microvessels, primary human cancer, mouse tumor organoids, stem
cells, and spatiotemporal control of oxygen. The technologies are part
of two early start-up companies, Kino Biosciences and Immunovalent
Therapeutics, based in Irvine, CA and St. Louis, MO. This seminar will
describe our approach to create a 3D in vitro model of human bone marrow
to assess the impact of ionizing radiation.
|
|